The Ensign Group, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from The Ensign Group, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 133.5 times by its yearly operating cash. Higher than 98% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$151Over the last 3 years, every $100 of reported profit came with $151 of operating cash.
Higher than 50% of Healthcare companies in United States.
Self-Funding Ratio
2.8×Over the last 3 years its own operating cash covered its investment spending (capex) 2.8 times.
Higher than 78% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$6Sales grew 67% in 3 years; of every extra $100 of sales, $6 became extra profit.
Lower than 61% of Healthcare companies in United States.
Asset Productivity Ratio
+67% / +58%In 3 years sales changed by +67% while total assets changed by +58%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
133.5×Debt due within a year is covered 133.5 times by its yearly operating cash.
Higher than 98% of Healthcare companies in United States.
Cash Cushion Ratio
−16%Debt, after subtracting cash, equals 16% of its market value (net debt).
Lower than 82% of Healthcare companies in United States.
Tangible Assets Ratio
98%Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 84% of Healthcare companies in United States.
Tangible Net Worth Ratio
95%Of every $100 of net worth, $95 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 81% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
The Ensign Group, Inc. owes $0.57 for every $1 it owns. Net profit rose 15% in the year to Dec 2025, and grew 15% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
28.0Investors pay $28.0 for every $1 of The Ensign Group, Inc.'s yearly profit, higher than 54% of Healthcare companies in United States.
P/B ratio
4.26The share price is 4.26 times The Ensign Group, Inc.'s book value per share, higher than 68% of Healthcare companies in United States.
Market cap
$10.4 BThe total market value of all of The Ensign Group, Inc.'s shares at today's price (share price × number of shares), larger than 90% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$2.4 BWhat The Ensign Group, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$41.89Net worth divided by the number of shares. The share price of $178.35 is 4.3 times this, which is the P/B above.
Return on equity (ROE)
17.0%The Ensign Group, Inc. earned 17.0% on its shareholders' money over the last year, higher than 88% of Healthcare companies in United States.
Owes vs Owns
0.57×The Ensign Group, Inc. owes $0.57 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.
Dividend yield
0.15%The Ensign Group, Inc. pays 0.15% of its share price as dividends a year, lower than almost all dividend-paying Healthcare companies in United States.
Revenue growth
+19%Revenue rose 19% in the year to Dec 2025, and grew 19% a year on average over 3 years.
Profit growth
+15%Net profit rose 15% in the year to Dec 2025, and grew 15% a year on average over 3 years.
Profit margin
6.8%The Ensign Group, Inc. keeps $7 of every $100 of revenue as net profit.
Cash quality
1.6×Cash from The Ensign Group, Inc.'s business was 1.6× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
53.2×The Ensign Group, Inc.'s operating profit covered its interest costs 53.2 times in the year to Dec 2025.
Cash vs debt
Net debtThe Ensign Group, Inc. had $1.6 B more debt than cash (net debt) at Dec 2025.
Questions
What is The Ensign Group, Inc.'s P/E ratio?
Investors pay $28.0 for every $1 of The Ensign Group, Inc.'s yearly profit, higher than 54% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For The Ensign Group, Inc.: $10.4 B ÷ $2.4 B (30 Jun 2026) = 4.3.
What is The Ensign Group, Inc.'s return on equity?
The Ensign Group, Inc. earned 17.0% on its shareholders' money over the last year, higher than 88% of Healthcare companies in United States.
How much does The Ensign Group, Inc. owe compared with what it owns?
The Ensign Group, Inc. owes $0.57 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.
Does The Ensign Group, Inc. pay a dividend?
Yes. The Ensign Group, Inc. pays 0.15% of its share price as dividends a year, lower than almost all dividend-paying Healthcare companies in United States.
Is The Ensign Group, Inc.'s revenue growing?
Revenue rose 19% in the year to Dec 2025, and grew 19% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.